Brief: Xbrane Biopharma Q4 EBITDA Loss Widens To SEK 61.3 Mln
26/02/2021 07:20
Feb 26 (Reuters) - Xbrane Biopharma AB XBRANE.ST :
* Q4 REVENUE SEK 0.0 MILLION VERSUS SEK 0.0 MILLION YEAR AGO
* Q4 EBITDA WAS SEK -61.3 M (-47.8*)
* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND BE PAID FOR
FINANCIAL YEAR 2020.
Source text for Eikon: ID:nMFN3wnKXx
Further company coverage: XBRANE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))